Navigation Links
An effective drug for lung cancer

According to a new study, a drug combination has the potential to double the life expectancy of patients with asbestos-related lung cancer called Mesothelioma. Mesothelioma is a cancer of the cells that make up the lining// around the outside of the lungs and inside of the ribs or around the abdominal organs. It differs from other types of lung cancers in that it is caused by exposure to asbestos, rather than by smoking.

The condition affects five times more men than women and most commonly occurs in men between 50 and 80 years old. Doctors say this cancer is very difficult to treat. People diagnosed with the disease generally only survive for six to eight months.

Researchers at Newcastle University in the United Kingdom conducted a clinical trial to determine if the anticancer drug combination of pemetrexed and carboplatin was safe in patients with Mesothelioma. Twenty-seven patients were treated with five different doses of the drugs.

The study found that not only was the drug safe, but about one-third of the patients responded to the drug combination. On average, patients who were given the drug combination survived as long as 12 to 14 months. A few cases, patients survived for three years or more. Researchers also report 80 percent of the patients noticed an improvement in symptoms, usually after only 2 treatments.

Doctors call this study an important development in the treatment of Mesothelioma. The clinical trial showed an improvement in survival and symptoms for the first time in patients with this disease. A multinational trial is now underway to study this treatment further.


'"/>




Page: 1

Related medicine news :

1. Morning after pill effective up to five days after having unprotected sex
2. Distraction therapy found very effective in postoperative patients
3. TELITHROMYCIN - the proven effective new drug for cap
4. Digital mammography proves effective
5. Treatment for pre-menstrual syndrome is ineffective
6. Cost-effective antibiotics for sinusitis treatment
7. An effective way to treat angina
8. Fluoride proves effective against fractures
9. Meningitis C vaccine a cost-effective success
10. Naltrexone effective for drinking problems
11. Ketoconazole 2% more effective in treating Seborrheic Dermatitis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its first-ever ... Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding work ... Practice and Pediatric Emergency Medicine Practice. , “With this award, we recognize ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... Today, MTI-GlobalStem, ... (iPS) cells and other difficult to transfect cells, announces its launch of the ... G9™ Gene Editing System is a complete system for culturing and transfecting ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Research and Markets has announced the addition ... report to their offering. ... The World Market for Companion Diagnostics covers the world ... in the report includes the following: , ... by Region (N. America, EU, ROW), 2015-2020 , World ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology: